Under a 15-year agreement, GE Healthcare has won the exclusive worldwide rights to distribute a stem cell harvesting technology developed by ThermoGenesis of Rancho Cordova, Calif. GE Healthcare also will distribute the California company's computer-controlled cryopreservation and storage system for cord blood....
Primorigen Biosciences, LLC, a producer of antibodies, microarrays, and other products for researchers, has attracted investments totaling almost $2.5 million to commercialize a technology invented in a Louisiana-based laboratory....
GenTel Biosciences, a producer of protein microarray technologies, has licensed a unique approach to cancer research for commercialization. The implications of the technology they develop could equip laboratories for the next generation of cancer research....
Dr. Marsha Seltzer, director of the University of Wisconsin-Madison's Waisman Center, has been appointed interim director of the new Wisconsin Institutes for Discovery. She will lead a collaborative effort to define the identity of the institutes and manage the first seed grant program for research....
GenTel BioSciences has won the right to commercialize a microarray technology used to measure variations in the glycosylation of proteins. The technology was developed by the Van Andel Research Institute in Michigan...
Perhaps the most definitive evaluation of U.S. hospitals is U.S. News & World Report's annual survey. Considering the sterling reputation of hospitals on both coasts, the Midwest fares surprisingly well, with four hospitals among the nation's top 14....
With an assist from the Madison-based NimbleGen, researchers in the U.S. and U.K. have identified the genetic causes of mental retardation. One form of retardation, caused by a large deletion that spans six genes on chromosome 17, has physical features that can aid clinicians in...
Genzyme Corp., the Boston-based biotechnology firm that purchased Bone Care International in 2005, is suing three former employees of Bone Care and their new company, Cytochroma, alleging the theft of BCI's trade secrets in the development of new products. The employees, which include former Bone...
David Snyder, the new chief financial officer for NimbleGen Systems, brings 15 years of experience with finance and general management at rapid-growth companies....
With all the claims and counter-claims about human embryonic stem cells, Tom Still provides an election-year tutorial, and helps voters avoid getting caught in the "spin" cycle. ...